Model N
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 161m | 193m | 219m | 249m | 262m | 285m | 314m |
| % growth | 14 % | 20 % | 13 % | 14 % | 5 % | 9 % | 10 % |
| EBITDA | (1.0m) | (6.7m) | (3.4m) | 13.2m | 49.1m | 57.7m | 67.5m |
| % EBITDA margin | (1 %) | (3 %) | (2 %) | 5 % | 19 % | 20 % | 21 % |
| Profit | (13.7m) | (29.7m) | (28.6m) | (33.9m) | 1.1m | 6.3m | 11.2m |
| % profit margin | (8 %) | (15 %) | (13 %) | (14 %) | - | 2 % | 4 % |
| EV / revenue | 7.0x | 6.0x | 5.5x | 3.7x | 4.2x | 3.7x | 3.1x |
| EV / EBITDA | -1097.9x | -174.1x | -355.3x | 69.3x | 22.6x | 18.2x | 14.5x |
| R&D budget | 34.4m | 44.7m | 47.6m | 48.5m | - | - | - |
| R&D % of revenue | 21 % | 23 % | 22 % | 19 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$26.0m | Growth Equity VC | ||
$11.0m | Series C | ||
| N/A | $104m Valuation: $332m | IPO | |
* | $50.0m | Post IPO Debt | |
* | N/A | $220m | Post IPO Equity |
* | $1.3b Valuation: $1.3b 5.0x EV/LTM Revenues 94.4x EV/LTM EBITDA | Buyout | |
| Total Funding | $37.0m | ||
Related Content
Recent News about Model N
EditModel N is a leading provider of cloud-based revenue management solutions tailored for the high-tech and life sciences industries. The company helps its clients maximize revenue at every stage of the commercialization process, from reshaping the quote-to-cash process to transforming engagement with channel partners and achieving excellence in global product launches. Model N's intelligent cloud platform is designed to empower companies to bring life-changing products to market faster while navigating new and upcoming regulatory changes.
Model N serves clients in the pharmaceutical, medical technology, and high-tech sectors. These industries often face complex pricing, compliance, and revenue management challenges. Model N addresses these challenges with industry-specific solutions such as Revenue Cloud for Pharma, Revenue Cloud for Medtech, and Revenue Cloud for High Tech. These solutions help companies manage provider and payer relationships, global pricing, tender management, and more.
The company's business model revolves around providing software-as-a-service (SaaS) solutions. This means clients subscribe to Model N's cloud-based platform, paying recurring fees for access to its suite of tools and services. This model ensures a steady stream of revenue for Model N while offering clients continuous updates and support.
Model N generates significant savings for its customers, with an average annual saving of $68 million per $1 billion of revenue. This impressive figure highlights the efficiency and value of their solutions. The company also offers webinars and other educational resources to help clients stay informed about industry trends and best practices.
In summary, Model N is a specialized provider of cloud-based revenue management solutions for the high-tech and life sciences industries, helping companies maximize revenue and navigate regulatory complexities.
Keywords: revenue management, cloud-based solutions, high-tech, life sciences, SaaS, pharmaceutical, medtech, compliance, pricing, commercialization.
